Sarepta Therapeutics (SRPT) Construction in Progress (2013)
Sarepta Therapeutics (SRPT) recorded quarterly Construction in Progress of $11.3 million in Q4 2013.
Sarepta Therapeutics (SRPT) Construction in Progress (2013) Analysis & Trends
Sarepta Therapeutics' Construction in Progress history runs 1 years deep, the most recent figure standing at $11.3 million for Q4 2013.
- In Q4 2013, Construction in Progress changed N/A year-over-year to $11.3 million; the TTM figure through Dec 2013 stood at $11.3 million (changed N/A YoY), while the FY2013 annual figure was $11.3 million, changed N/A from the prior year.
- Construction in Progress was $11.3 million for Q4 2013 at Sarepta Therapeutics.
- In the past five years, Construction in Progress ranged from a high of $11.3 million in Q4 2013 to a low of $11.3 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 11.30 Mn |